601 Lexington Avenue New York, New York 10022 |
||||
Daniel Wolf To Call Writer Directly: (212) 446-4884 daniel.wolf@kirkland.com |
(212) 446-4800
www.kirkland.com |
Facsimile: (212) 446-4900 |
October 17, 2013
VIA EDGAR SUBMISSION
David L. Orlic, Esq.
Special Counsel
Securities and Exchange Commission
Division of Corporation Finance, Office of
Mergers & Acquisitions
100 F Street, NE
Washington, DC 20549-3628
Re: | Greenway Medical Technologies, Inc. |
Schedule TO-T filed by Crestview Acquisition Corp., VCG Holdings,
LLC, Vista Equity Partners Fund IV, L.P., and Vitera Healthcare
Solutions, LLC
Filed on October 4, 2013, amended on October 8, 2013, October 11, 2013
and October 15, 2013
File No. 005-86773
Dear Mr. Orlic:
On behalf of our clients, Crestview Acquisition Corp. (Purchaser), VCG Holdings, LLC (Parent), Vitera Healthcare Solutions, LLC (Vitera), and Vista Equity Partners Fund IV, L.P. (Vista and together with Purchaser, Parent and Vitera, the Filing Persons), we are submitting this letter in response to the comments of the staff (the Staff) of the United States Securities and Exchange Commission (the Commission) in a letter dated October 16, 2013 (the Comment Letter), with respect to the Filing Persons Amendment No. 3 to Schedule TO-T filed with the Commission on October 15, 2013 (as amended, the Schedule TO), relating to Purchasers tender offer for all of the outstanding shares of common stock of Greenway Medical Technologies, Inc. (Greenway). The responses below correspond to the captions and numbers of those comments in your letter (which are reproduced below in italics). In addition, the Filing Persons are simultaneously filing Amendment No. 4 to the Schedule TO (Amendment No. 4) in response to the Comment Letter. Unless explicitly set forth herein, capitalized terms shall have the meanings ascribed to them in the Schedule TO.
Securities and Exchange Commission
October 17, 2013
Page 2
The Merger Agreement, page 33
1. | Disclosure has been retained to the effect that the merger agreement has been provided solely to inform investors of its terms, and that the companys stockholders and other investors are not third-party beneficiaries under the merger agreement. Please revise, as requested, to remove any potential implication that the merger agreement does not constitute public disclosure under the federal securities laws. |
Response:
In response to the Staffs comment, Amendment No. 4 amends this Section in accordance with the Staffs comment.
* * * * *
Securities and Exchange Commission
October 17, 2013
Page 3
Please do not hesitate to contact the undersigned at the number above with any questions or comments you may have regarding this letter or the Schedule TO.
Sincerely, |
/s/ Daniel Wolf |
Daniel Wolf |
cc: | Crestview Acquisition Corp. |
VCG Holdings, LLC
Vitera Healthcare Solutions, LLC
Vista Equity Partners Fund IV, L.P.
M;&@;:UU2:8>TQHIQ-3MWJ35"E,4,7@;D8QB$%WM'^U)J)H1)IQ9M5,L\ ML&_+/*PFL?9._I^]W!?$R0X]((36OG4C%S-S2::A*,.3-Z=&6I&46(_!N2BL M@!DO`(WV![&U:S_:R>;G:O[8;4:"WG%O MMQZ*W0=[6=`(^HSN17,I3*Q/:LXUM3")0G( 7)Y3H3 M6^,UBF&I:8^8ZFDMY:DQ08G(SG'/G(A"$$I3[L):YV9H>Z:"S387;23P:7WF M'8&T+?E-B1277W:TU3%8(:4LVG4I@CPD6,+,0D0@3D$H23`X;B U(K2U74=*I!4LOBHHG;4?J* M/$16)2BR*W/CJ"+NT[`P)"4QRXD)"?)9!>`)P>&>8)[T5[3-(Z4V9/MC7>R[ MJVLV\M)D*B\YVEV8EY <""$P`@9SCP M%C./''`9JZ^^V:IZH03,BG.Y-W5:<;[#E3O.)JRU-LI%ZZ8)'+7X61.T@<62 M*5 ',>F;],IS7 MUA0RQ(BFN"5VE.GM-(WRU9[8CU`'IX<9R%Z)&H3*T7H,)S#LY"'\A7($AZS] MEJ&:\[`078J4[T]P_:B4UBWRLNOHKM9L.5:]>Q:02M@6QDZ8HHL9$VD@Z1M3 M0YJ0(S#3!EDC.R/DR,(,A"<>VWVNZC[9#3?#+4-H7#8R+86T3+DFN;<<(4YJ M4D^7)CDCVZ,BB(PN'B((?"A$^>2?Z@(1)P9+R#Q'S`S+@#@#@#@#@#@#@#@% M)7YW&GJHNXG1FJB-C:55-2UO;81<-@*898BY9!KNMQHE#Q03*1.FY(&K65O7 M"AY")U;W964YGGR]D&D#D`C?$%ZX[U>RR+75.HF]:U-76VT 5[%A7(Z[4Q2D]P]-M56I4JI&5,C)*2]@IMJY')V_HYOF[G08II&D5RNYG0A M,Y1+=C+<,:Q9X'@&$SE;WV\DH+4.UGA'6R9SN_N!2?62PS36IX0,#-5#!;FQ M,&&_L^%$H&8UR5-'ZD;U)ZQ4>H1!-,4"RG"`0`EA1M/W>=GK+H'9ZRJ\;JFK M>:4S=U'OM=1^T*1N<)=B:?[5VK&*JI64FMLFE]7NIDWCCFM=Q/;LU]0CJY0W MDD)/+P<(P(2O:7<(W1JE+W1#EA%6R`&A,)A3=#)""BI@TU[/K(DU04%8JM8^ MROYU<5B!2B<;/7X]KD(,&Y:\I#L.XC`&@&%V*QVBO9LFV[-%7#BK9G8FJ]10 M"Y(U9]8QZ1Q6&REEM*)6.[,L2G,%>Y9,5\.GD9>:U4F*$Y+VI+<6-P0K`83" M-$7@%=OG=KWQK;4F(W3+J@KB=32UX[KS:M-G1&EKO0M R9=0UU-X?,:.HNE)/7=>F69$6E MQL:P3Y^7"9#,NN29*$D"D49`H&C)R>B_/Z32# M:D O*\U*$2 HSO;R: M<61'X-8
3A" M#L5._P!OG+)^RQ&EH+3\^?TJW8EP5UWBO9P)?.V:H=_ENK38UD3DFR4K+5!" M2J4QKVZ2!T2N*$MR29P!-R'`39"VFBNU%YVO;5V4SM6)KK*_(4D'+2M<_B-^ MB86"MS9Y*8M&[,K.ZCYQ*XKL95$K1($9/5T*9K6MSN6<0M1I!F%I@`T3@#@# M@#@#@#@#@#@#@#@#@#@#@#@*56;]#?L&^?E/XO\`87SK7_S[U_U'IOJ"]54? MQA[C\/W_`+\]7[+Z+Y'ZO/T[T_\`X^`B>S_XLOC.KOE?ZVXC\P=`\W^Z_#WMKHG5_']CY?I>?\`-ROGS' M\)?.?H*K^G7KOA[IZ=[])^&O:7IOR>F^1?#H/F?AU'G]/^?GX#I)']!G1[A] MS_$G1?JMJWYGZAS>E^K_`*G4'Q'[CYO_`%0ZO[*Z5R_J>=T_D_-RLZUZ#Y.ZE:/7?)]3^TZ_UGW9Z_T'X^J]9Y_ZGCP%L+S_ M`(YNM)/GGX1ZU\*5OZ;W/R>;\$?.$&^*>?T_Z7LSY]Z#T;S/R=<\GR?S^/`0 M+>/\-?S#LA\^?3I\N^W5GU0^\>H^IZ'\<1WU/R5S?V/U'Q7TSE\[]UT;R>3] M'PX"TNM?T)_!]A_3%\._"OJ9+\N^R_3^3U/VZ3[E^4/4?\EZY[1\CS.L?N^F M>1R?M_*X#I*E^C_FHGX>^.?#Z83OI[]N<_I_I5\ZN_4^P^;]M\?^9[7\WRO] MOH>;\OE\!62BOXE.C0OX"^G'I?SI5'QU[2Y/4?/OPZ1\2>R/,_N/N[Z?^3T/ MH/P]G>/-_;?'@)]I[Z'?1T+\,_%/3_C^\_I^]O>/HOCCW;&?G_VIY_[?V_[P MZ3UOG_)ZGR.;_;P%+VW^#WW'4W0OI7ZO\1M_Q'[=\WI'P?[NM#H/1>C?\<^. M?>?NSIGF_L/6>L]+^;QX#TV?_"QTBN/>GP1Z/X9ISV'[)]W]8^`_9LB^%O7_ M`!?_`'_XQ^.>I].ZI_;N@>=S_LO'@+"%_P`9GQM<'3_IX^)_?^N/S#[?Z9[( M]_\`1J;^EWJO0_[1ZOH7L;VMZ;]#T_3/(_+Y7`=Q1OT)?*XO@7XG^7O:UZ\W MM7G]Q^TOJ%6?4%_W?PZ9]2?G=<_PZ_S<_P";@.;TR_C[]RV3]'7L/WEZ-I]] M],]U^Z_:G57KV[TGW[_>OBOKG4.F]'_XUZSS_3_J^9P#`.`.`.`.`.`.`.`_ "_]D_ ` end
!,:J97$3.<>VF*A@R3ZP)U"8+ADVHG:_6?:%LEV`ZSP M+1J11_8NA:-J!Q@-X7=C$$.CSX M;&++AH0R2/5]1"16B2N2Q8!;_.O*LXI*22$K@>QL_P!>]J)>P_1'>_2B,4G# M5M+,]J5#M)$GES4ULEM6@;%"T&(&=D30^!OR5TEL/?!KG9!E<-*F^66G",>0 M_D`7;H/UW.-:]>MAZ0[G16LK"8+-L_:)YF$;C+TZRN(OL!OJWYE9C4D-7O,; MBCBAD#,FEH2LF$D8&D7(P*4Y_KP`0`X6*OKH[D5WIUVBZ9U? UFUZ@^%EW@41 32S0[FU56,(I2LJ^I^M&--&:]JZ&1J`0F/I/ M5E.S1:)-"1C8V\`QYR8;E,W(2PB,'G(S!8R(6 Q/4?8'L"(UB MK/2K;S5SL?ME\N67LNU4SFT"D=52N;M"EIFD8FS6P06 JH0%HL)&\@255 M\8.2_)(S#!C"_NNSKT[).KQUAE0P"^:.VJTJD7^\S>J+"Q.JFFNM\S?5)BZ4 MI]7'33 MFKML:>V-6K+JE4JC$6-0T]A_ "=P&Q%4;1U/LI$="*ZA]CZHW'5]=,M(6-=DP>I) I4'%M[6YKU1Q@`^K``9P(->.O37;NUU!H;5+3EUCW7"@I.E11:% MS6X&BQ]@)I:JNK4,A,=9,HC%?N%:PZ'FSM (&`YX&:6G1#L+;>Q^S]]2Y7K,3,Y9U=Q_55@?@K9N M 2V1L365JS^[K#1((;(&]Z^@*_DU=1?,+E$I`ARCPM M=G )4M-2M:,E"G,5J1 M^!J50R2,9,,S^1CSG.?WP(U&M&H'=7I+9F_<@H"!]<4WBNXVXEP[4L)MNW9L M(WR"%'V$N)(9V)U00ZFOX]W3H69N3C4%E*2!_)&9@)^08#G@7E<.E';(V=F5 M4]B-)H]'K(DD7T'BVIE@L5LV#<%;M4@FCE,S;(LN715OA=:34]D8B9*(*1F* M4JE)N46!"/#[GC/`]G;G2/M!W9KC1EZN;_QNS73K9V15MMM*8Q6\SM1OK)JI M6J"Q)F:#1F12.".THF-AR(2U4K5+%B5J0D"4`'H#YX$B/@.`X#@.`X#@.` =X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!__]D_ ` end